Parliament

Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search

 

Will NatLabs keep Pharmac out of US trade deal?

Will NatLabs keep Pharmac out of US trade deal?

Green Media Release 12th June 2008

The Green Party is calling on National and Labour to guarantee that Pharmac will not be undermined or weakened in trade negotiations with the United States. This follows news that Trade Minister Phil Goff is optimistic about US trade talks after meetings in Washington over the last two days.

"National and Labour are desperate to sign a trade deal with the US - it is a bipartisan position. I challenge them to provide a public guarantee that Pharmac will not be on the negotiating table in such a trade deal," says Dr. Russel Norman, Green Co-leader.

In the negotiations for the trade deal between Australia and the United States (AUSFTA), Australia's Pharmaceutical Benefits Scheme (PBS), similar to our Pharmac, was a major target of the US negotiators. The giant US drug companies see such schemes as threats to their profitability and use trade negotiations to undermine them.

"US negotiators are determined to break or undermine schemes that bulk-buy drugs and use generics or other measures to bring down the price of pharmaceuticals. Pharmaceutical prices in New Zealand and Australia are much lower than in the US because of Pharmac and the PBS.

In negotiations with Australia, the US demanded a series of changes to rules around funding of drugs and intellectual property laws. For example, generic drug makers are now required to notify patent drug manufacturers if they planned to introduce low cost copies of patent-expired drugs. This provides an opportunity for the big drug companies to use 'evergreening' techniques to stall the generic drugs. Another example is that an appeals mechanism was introduced whereby US drug companies can appeal decisions of the PBS not to fund their drugs.

"Pharmac saves the New Zealand taxpayer many millions of dollars every year by bulk purchasing drugs and by using generic drugs. The big US pharmaceutical companies hate this practice as it costs them profits. Pharmac estimated in 2004 that the measures in the AUSFTA would cost them $30m - $40m per year if adopted in New Zealand.

The US Trade Negotiator, Robert Zoellick, was congratulated at US Senate hearings on the AUSFTA, for having 'secured an agreement that would deliver higher prices paid by the PBS for US-patented drugs'.

"Not everyone agrees with every Pharmac decision, but that is no reason to give it up to US big pharmaceutical companies in trade negotiations.

"My challenge to Labour and National is to commit to keeping Pharmac out of US trade negotiations."

ENDS


© Scoop Media

 
 
 
 
 
Parliament Headlines | Politics Headlines | Regional Headlines

Gordon Campbell: On DHB Deficits And Free Trade

Currently the world is looking on aghast at the Trump administration’s plans to slash Obamacare, mainly in order to finance massive tax changes that will deliver most of their gains to the wealthy. Lives will be lost in the trade-off. Millions of Americans stand to lose access to the healthcare they need.

Spot the difference with New Zealand, where DHBs are under intense pressure to reduce deficits within a climate of chronic underfunding. More>>

 
 

Greens' Response: Slum-Like Rentals Exposed In Renting Review

“...The grim findings of the review are a wakeup call about the true state of rentals in this country. Too many renters are festering in slum-like conditions under the thumb of landlords who have largely unchecked powers and ignore tenants’ complaints when it suits them.” More>>

ALSO:

Gordon Campbell: On The Life And Times Of Peter Dunne

The unkind might talk of sinking ships, others could be more reminded of a loaded revolver left on the desk by his Cabinet colleagues as they closed the door behind them, now that the polls in Ohariu had confirmed he was no longer of much use to National. More>>

ALSO:

Gordon Campbell: On Labour’s Campaign Launch

One of the key motifs of Ardern’s speech was her repeated use of the phrase – “Now, what?” Cleverly, that looks like being Labour’s response to National’s ‘steady as it goes’ warning against not putting the economic ‘gains’ at risk. More>>

ALSO:

Lyndon Hood: Social Welfare, Explained

Speaking as someone who has seen better times and nowadays mostly operates by being really annoying and humiliating to deal with, I have some fellow feeling with the current system, so I’ll take this chance to set a few things straight.. More>>

ALSO:

Deregistered: Independent Board Decision On Family First

The Board considers that Family First has a purpose to promote its own particular views about marriage and the traditional family that cannot be determined to be for the public benefit in a way previously accepted as charitable... More>>

ALSO:

Transport Policies: Nats' New $10.5bn Roads Of National Significance

National is committing to the next generation of Roads of National Significance, National Party Transport Spokesperson Simon Bridges says. More>>

ALSO:

 
 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 
 

Featured InfoPages

Opening the Election